APLT
Price
$0.48
Change
+$0.01 (+2.13%)
Updated
Aug 15 closing price
Capitalization
69M
82 days until earnings call
TNFA
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
1.43M
Interact to see
Advertisement

APLT vs TNFA

Header iconAPLT vs TNFA Comparison
Open Charts APLT vs TNFABanner chart's image
Applied Therapeutics
Price$0.48
Change+$0.01 (+2.13%)
Volume$739.75K
Capitalization69M
TNF Pharmaceuticals
Price$0.10
Change-$0.00 (-0.00%)
Volume$24.06M
Capitalization1.43M
APLT vs TNFA Comparison Chart in %
Loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. TNFA commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and TNFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (APLT: $0.48 vs. TNFA: $0.10)
Brand notoriety: APLT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 43% vs. TNFA: 50%
Market capitalization -- APLT: $69M vs. TNFA: $1.43M
APLT [@Biotechnology] is valued at $69M. TNFA’s [@Biotechnology] market capitalization is $1.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, TNFA is a better buy in the long-term than APLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 4 TA indicator(s) are bullish while TNFA’s TA Score has 5 bullish TA indicator(s).

  • APLT’s TA Score: 4 bullish, 5 bearish.
  • TNFA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TNFA is a better buy in the short-term than APLT.

Price Growth

APLT (@Biotechnology) experienced а +12.57% price change this week, while TNFA (@Biotechnology) price change was +4.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

APLT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLT($69M) has a higher market cap than TNFA($1.43M). APLT YTD gains are higher at: -44.043 vs. TNFA (-91.217). TNFA has higher annual earnings (EBITDA): -8.35M vs. APLT (-108.32M). APLT has more cash in the bank: 50.8M vs. TNFA (5.88M). TNFA has less debt than APLT: TNFA (2.68K) vs APLT (2.7M). APLT has higher revenues than TNFA: APLT (265K) vs TNFA (0).
APLTTNFAAPLT / TNFA
Capitalization69M1.43M4,815%
EBITDA-108.32M-8.35M1,298%
Gain YTD-44.043-91.21748%
P/E RatioN/AN/A-
Revenue265K0-
Total Cash50.8M5.88M864%
Total Debt2.7M2.68K100,822%
FUNDAMENTALS RATINGS
APLT vs TNFA: Fundamental Ratings
APLT
TNFA
OUTLOOK RATING
1..100
7485
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6595
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (8) in the null industry is significantly better than the same rating for APLT (74). This means that TNFA’s stock grew significantly faster than APLT’s over the last 12 months.

TNFA's Profit vs Risk Rating (100) in the null industry is in the same range as APLT (100). This means that TNFA’s stock grew similarly to APLT’s over the last 12 months.

APLT's SMR Rating (98) in the null industry is in the same range as TNFA (100). This means that APLT’s stock grew similarly to TNFA’s over the last 12 months.

APLT's Price Growth Rating (65) in the null industry is in the same range as TNFA (95). This means that APLT’s stock grew similarly to TNFA’s over the last 12 months.

APLT's P/E Growth Rating (100) in the null industry is in the same range as TNFA (100). This means that APLT’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTTNFA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.310.08
+6.50%
Pacific Biosciences of California
LFMDP24.000.60
+2.56%
LifeMD
GMM2.25-0.01
-0.44%
Global Mofy AI Limited
HTHT33.07-0.15
-0.45%
H World Group Limited
DXPE116.96-1.80
-1.52%
DXP Enterprises

APLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLT has been loosely correlated with AMGXF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if APLT jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
+1.50%
AMGXF - APLT
33%
Loosely correlated
N/A
TNFA - APLT
28%
Poorly correlated
-1.27%
COEP - APLT
27%
Poorly correlated
+21.69%
EDIT - APLT
25%
Poorly correlated
+2.36%
PHAT - APLT
25%
Poorly correlated
-2.20%
More